Novo Nordisk reported an 8.5 per cent increase in revenues to 22.25bn kroner (€3bn) and profit up a little over 1 per cent to 6.5bn kroner in the third quarter, a little head of analyst ...

A patient advocacy group has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin ... have sent a letter (PDF) to Novo Nordisk to request more ...

The history of Novo Nordisk dates back to the time when insulin was discovered. In 1922, the Danish physiologist August Krogh met with to-be fellow Nobel Prize laureates Frederick Grant Banting ...

contain nutrients that promote healthy aging. Meal planning can help you add healthy aging foods to your daily diet and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Nestlé's new food line, Vital Pursuit, is specifically targeted toward patients using weight-loss medications, which continues to surge in popularity. Novo Nordisk has been slowly increasing ...

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity ...

Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that works differently than its already-popular weight loss drug Wegovy.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...